Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Dummer

C. Wade Dummer, Layton, UT US

Patent application numberDescriptionPublished
20080255541PERCUTANEOUS ACCESS SYSTEM - A transition device for placement at the opening of the tip of a cannula body for the purpose of controlling the shape of the cannula tip opening under various loads such as might be encountered during device placement.10-16-2008

Jonathan Leigh Dummer, Redding, CA US

Patent application numberDescriptionPublished
20110025337SYSTEM AND METHOD OF TESTING HIGH BRIGHTNESS LED (HBLED) - A system and method of testing High Brightness LED (HBLED) is provided, and more particularly, a system and method of Controlled Energy Testing of HBLED with improved accuracy and repeatability is provided. In one embodiment, the system includes a programmable constant power source for providing a constant power to a Device Under Test (DUT), in this case, an HBLED, wherein the programmable constant power source adjusts an output voltage or an output current to ensure that a given amount of power is supplied to the HBLED for a predetermined amount of time and to provide precise control of a junction temperature of the HBLED for the duration of the test sequences; a Parametric Measurement Unit (PMU) including a processor for executing a plurality of HBLED test sequences, and a spectrometer for measuring a set of HBLED parameters including power and color (wavelength) of an optical output of the HBLED; and a controller for coordinating timing of acquiring the set of measured HBLED parameters. In another embodiment, a photodetector is implemented to measure the integrated power of the optical output of the HBLED.02-03-2011

Wolfgang Dummer, San Francisco, CA US

Patent application numberDescriptionPublished
20080299117Treatment Method - The invention provides methods of treating autoimmune diseases using lower doses of anti-CD20 antibodies of 100 mg to 200 mg effective to deplete B cells in the patient.12-04-2008
20090169550THERAPY OF RITUXIMAB-REFRACTORY RHEUMATOID ARTHRITIS PATIENTS - A method is disclosed of treating a rituximab-refractory rheumatoid arthritis (RA) patient comprising administering an anti-CD20 antibody other than rituximab to the patient in an amount effective to treat the RA.07-02-2009

Patent applications by Wolfgang Dummer, San Francisco, CA US